SCHEMBL24919787

SCHEMBL24919787

c1ccc(-c2ccc(-c3ccc(N(c4cccc(-c5cccc6ccccc56)c4)c4ccccc4-c4ccc5oc6ccccc6c5c4)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.38
▸ ACMSD Q8TDX5 1/20 0.38
▸ PLA2G2A P14555 2/20 0.35
▸ PLA2G4A P47712 2/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ MAPT P10636 5/20 0.34
▸ HPGD P15428 5/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ TSHR P16473 3/20 0.34
▸ PLA2G10 O15496 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24919125 1.00 MCL1 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23233229 0.98 PLA2G2A (0.37) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23233115 0.98 CA12 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23233088 0.98 CA12 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23237671 0.98 PLA2G2A (0.37) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23233251 0.98 PLA2G2A (0.37) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL24963777 0.98 CA12 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23239369 0.98 PLA2G2A (0.37) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23225194 0.98 CA12 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5
SCHEMBL23224491 0.98 CA12 (0.38) MCL1ACMSDPLA2G2APLA2G4AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX MCL1 3058/4885ACMSD 2451/4885PLA2G2A 3282/4885
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 MCL1 1725/4885ACMSD 1115/4885PLA2G2A 4366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback